- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04727762
Use of the Mask and Current Pandemic (Mask)
Population Impact on the Continued Use of the Mask Due to the Avoidance of COVID-19
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Introduction
Due to the continued use of the mask in order to prevent the spread of COVID-19, an impact on people is observed in different areas. The objective of our study was to collect impact aspects related to the continued use of the mask that may affect the quality of life of the population.
Material and methods
Diseny. For this, an observational study has been carried out that includes an interview with aspects related to headaches, problems in the temporomandibular joint, headache impact and quality of life.
Participants. Subjects of all ages from 18 years old will be recruited who use a mask daily for the avoidance of COVID-19 and with the ability to answer the questions and complete the questionnaires. The study will be carried out at the Faculty of Physiotherapy of the University of Valencia. The participants will sign an informed consent guaranteeing the confidentiality of the data. The study is approved by the ethics committee of our institution.
Outcomes. The sociodemographic characteristics and the use of the mask will be collected. Subsequently, the evaluation instruments without the use of a mask and with the use of the same in: Headache and the impact on headaches, pain related to temporomandibular joint and quality of life.
All data will be coded in a database and analyzed later.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Valencia, Spanien, 46010
- Gemma Victoria Espí-López
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- from 18 years old will be recruited who use a mask daily for the avoidance of COVID-19.
- that they use the face mask at least 2 hours a day
- with the ability to answer the questions and complete the questionnaires.
Exclusion Criteria:
- I do not use the mask
- institutionalized subjects
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Headache
Tidsramme: 1 day
|
An ad hoc questionnaire will be carried out that includes a question about the existence of headache before and after the use of the mask with a dichotomous response (Yes, No) and another about the frequency of headache with the options of daily, weekly or monthly.
|
1 day
|
|
Pain Temporomandibular Joint
Tidsramme: 1 day
|
The ad hoc questionnaire will include two questions about the existence of joint discomfort in the TMJ before and after the use of the mask with a dichotomous response (Yes, No) and pain when chewing evaluated using the Visual Analog Scale (VAS).
|
1 day
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Headache Impact
Tidsramme: 1 day
|
Headache Impact Test-6 (HIT-6).To measure the impact of headache.
The score is calculated as follows: never (6 points), few times (8 points), sometimes (10 points), very often (11 points) and always (13 points).
With a total of 49 or less points is considered "little or no impact", between 50-55 "some impact", between 56-59 "significant impact" and 60 or more "very severe impact".
|
1 day
|
|
Influence on quality of life
Tidsramme: 1 day
|
Will be measured by Cantril Ladder of Life Scale (LADER).
The Cantril Staircase (Cantril 1965), measures satisfaction with life.
The subject is asked to imagine his life in the best possible way and to describe his hopes and wishes.
You are then asked to imagine your future in the worst possible light, your fears and concerns associated with this outcome.
Subsequently, the respondent is presented with an image consisting of a ladder numbered from zero to ten, where the top of the ladder represents the best possible life for the subject = 10 and the bottom of the ladder represents the worst possible life = 0.
|
1 day
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Gemma V Espí-López, fisiotherapy
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- ID0031
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Klem ansigtsmaske
-
RWTH Aachen UniversityAfsluttetAnæstesi med brug af LMA (Laryngeal Mask Airway)Tyskland
-
Zagazig UniversityRekrutteringSupraglottiske luftvejsanordninger | Laryseal Clear Laryngeal MaskEgypten
-
Ankara Diskapi Training and Research HospitalAfsluttetEffektiv I-Gel Mask Airway Placement-teknikKalkun
-
XiQiang HuangSun Yat-sen UniversityUkendtKropsvægt | Komplikation | Størrelse af Larynx Mask Airway | Succesrate for første forsøg
-
Eidos Therapeutics, a BridgeBio companyAfsluttetFamiliær ATTR-CM (ATTRm-CM eller FAC) | Vildtype ATTR-CM (ATTRwt-CM)Forenede Stater
-
Alnylam PharmaceuticalsAfsluttetAmyloide neuropatier | Amyloide neuropatier, familiær | Amyloidose, arvelig | Transthyretin (TTR) medieret familiær amyloidotisk kardiomyopati (FAC) | Amyloidose, arvelig, transthyretin-relateret | Familiær transthyretin hjerteamyloidoseForenede Stater, Frankrig, Italien, Spanien, Canada, Tyskland, Belgien, Sverige, Det Forenede Kongerige